JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120748

Ouabain octahydrate, Na+/K+ ATPase inhibitor

Be the first to review this product! Submit a review

|

(2 Publications)

MW 728.78 g/mol, Purity >97%. Na+/K+ ATPase inhibitor (Ki = 30 μM). Cardiac glycoside. Stimulates activity at low nanomolar concentrations in rats. Improves cardiac function in myocardial infarction rats. Centrally active following oral administration.
1 Images
Chemical Structure - Ouabain octahydrate, Na+/K+ ATPase inhibitor (AB120748)
  • Chemical Structure

Lab

Chemical Structure - Ouabain octahydrate, Na+/K+ ATPase inhibitor (AB120748)

2D chemical structure image of ab120748, Ouabain octahydrate, Na+/K+ ATPase inhibitor

Key facts

CAS number

11018-89-6

Purity

>97%

Form

Solid

form

Source

ripe seeds of African plants Strophanthus gratus and the bark of Acokanthera ouabaio

Molecular weight

728.78 g/mol

Nature

Native

Solubility

Soluble in DMSO to 100 mM

Soluble in ethanol to 10 mM

Soluble in water to 10 mM

Biological description

Na+/K+ ATPase inhibitor (Ki = 30 μM). Cardiac glycoside. Stimulates activity at low nanomolar concentrations in rats. Improves cardiac function in myocardial infarction rats. Centrally active following oral administration.

IUPAC Name

(1β,3β,5β,11α)-3-[(6-Deoxy-α-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide

Product details

It has been reported that an aqueous solution of this material stored overnight in a borosilicate glass vial leads to the formation of ouabain-borate complexes.
It is therefore recommended that this material is stored in a plastic vial and any contact with borosilicate glass is minimised.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in pharmacology 15:1433137 PubMed39295937

2024

PFKFB3 deprivation attenuates the cisplatin resistance via blocking its autophagic elimination in colorectal cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Qianqian Li,Jianxing Ma,Yaqin Zhang,Fengyao Sun,Wen Li,Wenzhi Shen,Zhiying Ai,Changli Li,Shanshan Wang,Xiaonan Wei,Siyuan Yan

Nature communications 13:7136 PubMed36414629

2022

Activated astrocytes attenuate neocortical seizures in rodent models through driving Na-K-ATPase.

Applications

Unspecified application

Species

Unspecified reactive species

Junli Zhao,Jinyi Sun,Yang Zheng,Yanrong Zheng,Yuying Shao,Yulan Li,Fan Fei,Cenglin Xu,Xiuxiu Liu,Shuang Wang,Yeping Ruan,Jinggen Liu,Shumin Duan,Zhong Chen,Yi Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com